Diffuse malignant epithelial peritoneal mesothelioma in pregnancy. A case report and literature review

A 33-year-old pregnant woman of 38 weeks' gestation with massive peritoneal ascites presented. A cesarean section was performed and a viable 3.100 g male infant was delivered. Biopsy of the nodular enlargements from the omentum revealed a malignant epithelial peritoneal mesothelioma. Malignant mesothelioma is a rare malignancy which has not been described in term pregnancy and appears to be unaffected by the pregnant state.

Diffuse malignant epithelial peritoneal mesothelioma; Pregnancy; Histochemistry; Immunohistochemistry

[1] Sridhar K. S.. Doria R.. Raub W. A. Jr.. Thurer R. J.. Saldana M.: "New strategies are needed in diffuse malignant mesothelioma" Cancer, 1992, 70, 2969.

[2] Asensio J. A.. Goldblatt P., Thomford N. R.: "Primary malignant peritoneal mesothelioma. A report of seven cases and a review of the literature". Arch. Surg., 1990, 125, 477.

[3] Antman K. H.: "Malignant mesothelioma". N. Engl. J. Med., 1980, 303, 200.

[4] Walker Am., Loughlin J. E.. Freidlander E. R.: "Projections of asbestos-related disease, 1980-2009". J. Occup. Med., 1983, 25, 409.

[5] Hammar S. P., Bolen J. L.: "Pleural neoplasms". In: Dail H. D., Hammar S. P. (eds.): "Pulmonary Pathology" I" ed., New York, Springer-Verlag, 1988, 973.

[6] Johnsen B. L., Lee I., Gould V.: "Epidemiology, pathogenesis, and pathology". In: "Mesothelioma Diagnosis and Management" Kittle F. C. (ed.), Chicago, Year Book Medical, 1987, 1.

[7] Donna A., Betta P. G., Bellingeri D., Marchesini A.: "New marker for mesothelioma: an immunoperoxidase study". J. Clin. Pathol., 1986, 39, 961.

[8] Hsu S-M., Raine L., Fauger H.: "Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures". J. Histochem. Cytochem., 1981, 29, 577.

[9] Clover J., Oates J., Edwards C.: "Anti-cytokeratin 5/6: A positive marker for epithelioid mesothelioma". Histopathology, 1997, 31, 140.

[10] Ordonez N. E.: "Value of cytokeratin 5/6 immunostaining in distinguishing epithelial mesothelioma of the pleura from lung adenocarcinoma". Am. J. Surg. Pathol., 1998, 22, 1215.

[11] Yates D. H., Corrin B., Stidoph P. N., Brownek.: "Malignant mesothelioma in southeast England: Clinicopathological experience of 272 cases". Thorax, 1997, 52, 507.

[12] Price B.: "Analysis of current trends in United States mesothelioma incidence". Am. J. Epidemiol., 1997, 145, 211.

[13] Ramsey P. S., Danilenko-Dixon D. R.. Ramin K. D., Ogburn P. L Jr.: "Malignant pleural mesothelioma in pregnancy". J. MaternaFetal. Med., 2000, 9, 373.

[14] Sebbag G., Yan H., Shmookler B. M., Chang D., Sugarbaker P. H.: "Results of treatment of 33 patients with peritoneal mesothelioma". Br. J. Surg., 2000, 87, 1587.

[15] Kannerstaein M., Churg J.: "Peritoneal mesothelioma". Hum Pathol., 1977, 8, 83.

[16] McCaughey W. T. E.: "Papillary peritoneal neoplasms in females". In: "Pathology Annuals, Part 2". Sommers S. C., Rosen P. P., Fechner R. E.. (eds.). New York, Appleton-Century-Crofts, 1985, 387.

[17] Goldblum J., Hart W.R.: "Localized and diffuse mesotheliomas of the genital tract and peritoneum in women". Am. J. Surg. Pathol., 1995, 19 (10), 1124.

[18] Churg A., colby T. V., Cagle P., Corson J., Gibbs A. R., Gilks B., et al.: "The separation of benign and malignant mesothelial proliferations". Am. J. Pathol., 2000, 24, 1183.

[19] Clement P. B.. Young R. H.: "Atlas of Gynecologic Surgical Pathology". Philadelphia, W. B. Saunders, 2000, 456.

[20] Ordonez N. E.: "Role of immunohistochernistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas". Am. J. Surg. Pathol., 1998, 22, 1203.

[21] Bollinger D. J., Wick M. R., Dehner L. P., Mills S. E., Swanson P. E., Clarke R. E.: "Perithoneal malignant mesothelioma versus serous papillary adenocarcinoma: A histochemical and immunohistochemical comparison". Am. J. Surg. Pathol.,1989, 13, 659

[22] Rogof E. E., Hilaris B. S., Huvos A. G.: "Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation". Cancer, 1973, 32, 656.

[23] Rose R. G., Palmer J. D., Lougheed M. N.: "Treatment of pentoneal mesothelioma with radioactive colloidal gold. Report of a case". Cancer, 1955, 8, 478.

[24] Eltabbakh G. H., Piver M. S., Hempling R. E., Recio F. O., Intengen M. E.: "Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma". J. Surg. Oncol., 1999, 70, 6.

[25] Markman M., Kelsen D.: "Efficacy of cisplatin-based intrapentoneal chemotherapy as treatment of malignant peritoneal mesothelioma". J. Cancer Res. Clin. Oncol., 1992, 118, 547.

[26] Park B. J., Alexander H. R., Libutti S. K., Wu P., Royalty D., Kranda K. C. et al.: "Treatment of primary peritoneal peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP)". Am. Surg. Oncol., 1999, 6, 582.

[27] Tsavaris N., Primikiros N., Mylonakis N., Varouchakis G.. Dosios T., Pavlidis N. et al.: "Combination chemotherapy with cisplatin and/or doxorubicin in malignant mesothelioma. A retrospective study". Anticancer Res., 1997, 17, 3799.

[28] Read E. J., Platzer P. B.: "Placental metastasis from maternal carcinoma of the lung". Ohstet. Gynecol., 1981. 38, 387.